Receptor activated Ca(2+) release is inhibited by boric acid in prostate cancer cells.
BACKGROUND:The global disparity in cancer incidence remains a major public health problem. We focused on prostate cancer since microscopic disease in men is common, but the incidence of clinical disease varies more than 100 fold worldwide. Ca(2+) signaling is a central regulator of cell proliferatio...
Main Authors: | Kimberly Henderson, Salvatore L Stella, Sarah Kobylewski, Curtis D Eckhert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2698284?pdf=render |
Similar Items
-
Effects of EDTA and Boric Acid on the Morphology of CaCO3 Particles
by: Xingbo Shi, et al.
Published: (2012-01-01) -
Boric Acid Containing Polyimide as a Route to Low Heat Releasing Materials
by: Köytepe, Süleyman, et al.
Published: (2009-06-01) -
The multistep decomposition of boric acid
by: Clemens Huber, et al.
Published: (2020-05-01) -
Boric acid and mineral waters
by: Munteanu Constantin, et al.
Published: (2011-05-01) -
Boric acid inhibits germination and colonization of Saprolegnia spores in vitro and in vivo.
by: Shimaa E Ali, et al.
Published: (2014-01-01)